ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2018

Development of an Osteoporosis Treatment Gap Dashboard

Rulan Lyu1, Patrick O'Brien1, Tracey Wilkie1, Yun Chang1 and Jonathan Cheah2, 1UMass Memorial Health, Worcester, MA, 2UMass Chan Medical School, Shrewsbury, MA

Meeting: ACR Convergence 2023

Keywords: osteoporosis, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis and the clinical event of fragility fracture is an ever-increasing public health burden. A significant osteoporosis treatment gap remains, whereby individuals with a fragility fracture are never prescribed therapies for fracture risk reduction. In addition, recent specialty guidelines for the treatment of osteoporosis have started to risk stratify individuals for the purposes of sequential treatment strategies over time. The aim of this work is to utilize multiple sources of data within the electronic medical record (EMR) to identify individuals eligible, but who have not yet received therapies for fracture risk reduction who can then be targeted for intervention.

Methods: Within a single academic health system and focusing on the criteria distinguishing between high- and very high-risk patients as described by specialty guidelines relating to osteoporosis treatment, candidate items were identified to be incorporated into the dashboard. These included 1: demographic data such as race/ethnicity and primary insurance coverage, 2: ICD10 codes on problem lists relating to osteoporosis and fracture, 3: abstraction of T-scores from dual energy x-ray absorptiometry scans, 4: abstraction of vertebral compression fractures from CT and MRI reports and 5: information on prescriptions for FDA-approved medications for fracture risk reduction. The Epic Caboodle database was utilized to obtain most of the data, however, data relating to T-scores and vertebral compression fractures were abstracted separately. Once these individual pieces of data were identified, a treatment dashboard was created to present this data in an actionable format.

Results: An osteoporosis treatment gap dashboard was created (Figure 1) to identify individuals who meet diagnosis for osteoporosis by: ICD 10 code, T-score, vertebral compression fracture noted on CT or MRI reports and to stratify individuals by risk level (presence of fracture, very low t-score), as well as a number of other factors such as age, race/ethnicity, primary care provider and primary insurance coverage. Information on whether an individual has received a therapy for fracture risk reduction is also included. Specific lists of individuals can be generated accordingly, for example by primary care practice, or risk level of future fracture, to allow for locally guided interventions to address the osteoporosis treatment gap.

Conclusion: An osteoporosis treatment gap dashboard has been created which is able to identify and risk stratify individuals who per specialty guidelines would qualify for therapies for fracture risk reduction. Additional work is underway to utilize this dashboard with the aim to reduce the osteoporosis treatment gap.

Supporting image 1

Figure 1: high level overview of osteoporosis treatment gap dashboard


Disclosures: R. Lyu: None; P. O'Brien: None; T. Wilkie: None; Y. Chang: None; J. Cheah: AbbVie/Abbott, 1.

To cite this abstract in AMA style:

Lyu R, O'Brien P, Wilkie T, Chang Y, Cheah J. Development of an Osteoporosis Treatment Gap Dashboard [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/development-of-an-osteoporosis-treatment-gap-dashboard/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-an-osteoporosis-treatment-gap-dashboard/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology